Skip to main content

Incretin Mimetics (GLP-1 Agonists)

Medically reviewed by Melisa Puckey, BPharm. Last updated on April 10, 2024.

Other names: GLP-1 Analogues, GLP-1 Receptor Agonists, glucagon-like peptide 1 agonists

What are Incretin Mimetics (GLP-1 Agonists)?

GLP-1 agonists are medications that help with weight loss and type 2 diabetes by mimicking the GLP-1 hormone. They increase insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite. These effects lead to decreased caloric intake and improved satiety, and for type 2 diabetes, they improve blood sugar levels. Common examples include liraglutide and semaglutide. Clinical trials show significant weight loss and improvement in blood sugar levels, but side effects like nausea and vomiting can occur.

List of Incretin Mimetics (GLP-1 Agonists)

View by  Brand | Generic
Drug Name Avg. Rating Reviews
liraglutide systemic (Pro)
7.6
 2,324 reviews
semaglutide systemic (Pro)
6.7
 2,170 reviews
tirzepatide systemic (Pro)
8.6
 1,175 reviews
dulaglutide systemic (Pro)
5.2
 990 reviews
exenatide systemic (Pro)
6.4
 416 reviews
albiglutide systemic
4.6
 11 reviews
lixisenatide systemic (Pro)
No reviews
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

See also

Medical conditions treated or associated with Incretin Mimetics (GLP-1 Agonists):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer